UK-based Alliance Pharma saw sales rise double-digits in 2021, with acquisitions bolstering the performance of its established brands. Going into 2022, the company says it is in a strong position to pursue M&A in the consumer health space.

GSK says London-based Unilever's £50bn bid for Consumer Healthcare fundamentally undervalues a business which generated sales close to £10bn last year and is expected to grow 4-6% over the medium term. The rejection has not dissuaded Unilever, however, with the company intent on stepping up its presence in the health, beauty and hygiene categories.

Perrigo largely has resolved distribution problems, but shipping freight costs still are much higher than pre-pandemic and it must divest a wound-care brand before US regulators sign off on acquisition of HRA Pharma, says CEO Murray Kessler during J.P. Morgan conference.

Galenica's Swiss consumer health business Verfora saw sales jump by a fifth in 2021 thanks to key acquisitions. Without the impact of these deals, Verfora's sales over the 12 months would have declined due to the negative impact of the pandemic on its business.

Around 1,500 senior and junior management roles will be cut under Unilever’s announced plan to reshape its corporate matrix, the firm reports on 25 January. The news comes a day after reports that activist investor Nelson Peltz of Trian Fund Management has taken a stake in the business.

While target date for spinning out consumer business into publicly traded company remains some time in 2023, J&J includes additional details on separation timetable with its 2021 full-year and fourth-quarter results.

Galenica's Swiss consumer health business Verfora saw sales jump by a fifth in 2021 thanks to key acquisitions. Without the impact of these deals, Verfora's sales over the 12 months would have declined due to the negative impact of the pandemic on its business.

While target date for spinning out consumer business into publicly traded company remains some time in 2023, J&J includes additional details on separation timetable with its 2021 full-year and fourth-quarter results.

Major Europe-based consumer health players GSK, Sanofi, Bayer and Reckitt feature in this earnings preview, which highlights what to look out for as these four firms report their Q4 and annual results over the coming weeks.

FDA worked on investigations with US Attorneys’ offices and other federal agencies of unlawful sales of supplements promoted to prevent or treat COVID-19 as well as other diseases and health conditions and of prescription drugs offered OTC for muscle growth or sexual enhancement.

Members of Congress in favor of giving FTC authority to impose monetary relief orders against firms linked to false advertising likely were caught off guard when West Virginia Democrat said he wouldn’t vote for legislation with $2.2 trillion for climate change, tax and social programs that President Biden made a primary plank of his Capitol Hill strategy and that the House passed in November.

Procter & Gamble and Amazon are among nine companies FTC ordered to provide detailed information to help the agency identify causes behind ongoing supply chain disruptions. Chairwoman Khan says the information should “shed light on market conditions and business practices that may have worsened these disruptions.”